Overview of comments received on ‘Levothyroxine tablets 12.5 mcg, 25 mcg, 50 mcg, 75 mcg, 100 mcg (and additional strengths) and 200 mcg product-specific bioequivalence guidance’ (EMA/CHMP/176098/2020)…
Europe – Overview of comments received on ‘Levothyroxine tablets
